Clinical Trials Directory

Trials / Completed

CompletedNCT02356679

Efficacy and Safety of Eupasidin-s Tab.(EUPASIDIN-S) in Gastritis Patients

A Phase 4, Multicenter, Randomized, Open, Active Drug Comparative Trial to Evaluated the Efficacy and Safety of EUPASIDIN-S Tab. in Gastritis Patients

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
230 (actual)
Sponsor
Chong Kun Dang Pharmaceutical · Industry
Sex
All
Age
19 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is evaluate the Efficacy and Safety of EUPASIDIN-S Tab. in Gastritis Patients.

Conditions

Interventions

TypeNameDescription
DRUGEupasidin-s Tabthree times per day, 1 tab for each time, PO, during 2weeks
DRUGStillen Tab.three times per day, 1 tab for each time, PO, during 2weeks

Timeline

Start date
2014-08-01
Primary completion
2015-06-01
Completion
2015-06-01
First posted
2015-02-05
Last updated
2015-08-24

Locations

10 sites across 1 country: South Korea

Source: ClinicalTrials.gov record NCT02356679. Inclusion in this directory is not an endorsement.